Journal of Antimicrobial Chemotherapy Issues Research Articles in September 2022 Edition
August 26, 2022
August 26, 2022
BIRMINGHAM, England, Aug. 26 -- The Journal of Antimicrobial Chemotherapy, a journal in antimicrobial research from the British Society for Antimicrobial Chemotherapy, published research articles on the following topics in its September 2022 edition:
Reviews:
* The primary pharmacology of ceftazidime/avibactam: in vitro translational biology
* The primary pharmacology of ceftazidime/avibactam: in vivo translational biology and pharmacokinetics/pharmacodyna . . .
Reviews:
* The primary pharmacology of ceftazidime/avibactam: in vitro translational biology
* The primary pharmacology of ceftazidime/avibactam: in vivo translational biology and pharmacokinetics/pharmacodyna . . .